Inventor · disambiguated record
Yeheng Zhu
Also filed as: ZHU YEHENG
19 granted patents·7 pending applications·66 citations·filing 2005–2021
92Inventor score
Top patents by PatentIndex Score
26 records- 0196US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0291US7417028B2Human glucagon-like-peptide-1 modulators and their use in treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·20 cites·22 claims
- 0390US10435369B2Tricyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 8, 2019·6 cites·6 claims
- 0487US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 0586US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 0686US7534763B2Sustained release GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted May 19, 2009·5 cites·25 claims
- 0784US7629342B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Dec 8, 2009·7 cites·20 claims
- 0879US10676477B2Factor XIa macrocycle inhibitors bearing a non-aromatic P2' groupBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 9, 2020·2 cites·12 claims
- 0978US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 1078US7361766B2Bicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Apr 22, 2008·3 cites·6 claims
- 1177US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 1277US7960349B2N-terminally modified GLP-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jun 14, 2011·2 cites·18 claims
- 1372US8030306B2Azabicyclic heterocycles as cannabinoid receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Oct 4, 2011·1 cites·13 claims
- 1461US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 1559US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 1656US2008242593A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditionsBRISTOL MYERS SQUIBB CO·Filed 2008·Application pending·0 cites
- 1754US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 1851US2010022457A1Sustained release glp-1 receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2006·Application pending·0 cites
- 1946US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2045US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 2142US11192891B2Diazaspiro ROCK inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Dec 7, 2021·0 cites·12 claims
- 2241US9346852B2Substituted adipic acid amides and uses thereofSUN CHONGQING·Filed 2012·Granted May 24, 2016·0 cites·13 claims
- 2341US2007021346A1N-terminally modified GLP-1 receptor modulatorsEWING WILLIAM R·Filed 2006·Application pending·0 cites
- 2440US8710049B2Diaminocyclohexane compounds and uses thereofEWING WILLIAM R·Filed 2012·Granted Apr 29, 2014·0 cites·10 claims
- 2538US10287288B2Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moietiesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 14, 2019·0 cites·11 claims
- 2637US8815909B2Diaminocyclohexane compounds and uses thereofEWING WILLIAM R·Filed 2012·Granted Aug 26, 2014·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yeheng Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →